Monotherapy with pixantrone in histologically confirmed relapsed or refractory aggressive B‐cell non‐Hodgkin lymphoma: post‐hoc analyses from a phase III trial

por Pettengell, Ruth, Sebban, Catherine, Zinzani, Pier Luigi, Derigs, Hans Gunter, Kravchenko, Sergey, Singer, Jack W., Theocharous, Panteli, Wang, Lixia, Pavlyuk, Mariya, Makhloufi, Kahina M., Coiffier, Bertrand
Publicado 2016

Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic (18)F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group

por Sachpekidis, Christos, Karampinis, Ioannis, Jakob, Jens, Kasper, Bernd, Nowak, Kai, Pilz, Lothar, Attenberger, Ulrike, Gaiser, Timo, Derigs, Hans-Günter, Schwarzbach, Matthias, Hohenberger, Peter, Dimitrakopoulou-Strauss, Antonia, Ronellenfitsch, Ulrich
Publicado 2019

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)

por Ronellenfitsch, Ulrich, Dimitrakopoulou-Strauss, Antonia, Jakob, Jens, Kasper, Bernd, Nowak, Kai, Pilz, Lothar R, Attenberger, Ulrike, Gaiser, Timo, Egerer, Gerlinde, Fröhling, Stefan, Derigs, Hans-Günter, Schwarzbach, Matthias, Hohenberger, Peter
Publicado 2016